PharmaCyte Biotech (PMCB) Change in Accured Expenses (2010 - 2026)
PharmaCyte Biotech's Change in Accured Expenses was -$177,175 in fiscal Q1 2027 (quarter ended Jul 31, 2026), compared with -$1.01 million a year earlier.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Change in Accured Expenses (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, PharmaCyte Biotech's Change in Accured Expenses was -$719,000 through Jul 31, 2026; for FY2026 (ended Apr 30, 2026), it came in at -$1.55 million.
- In earlier fiscal years, Change in Accured Expenses was $1.31 million in FY2025 (+590.0%), $189,923 in FY2024, -$40,709 in FY2023 and -$2,703 in FY2022.
- Quarterly Change in Accured Expenses has moved between -$1.01 million (fiscal Q1 2026) and $1.36 million (fiscal Q4 2025) over five years.
- Per Business Quant data, PMCB's Change in Accured Expenses in the three fiscal quarters before Q1 2027 was $77,175 (Q4 2026), -$544,000 (Q3 2026) and -$75,000 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | PharmaCyte Biotech | 4.29 Mn | 4.29 Mn | - | -177,175.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -177,175.00 |
| Apr 30, 2026 | 77,175.00 |
| Jan 31, 2026 | -544,000.00 |
| Oct 31, 2025 | -75,000.00 |
| Jul 31, 2025 | -1.01 Mn |
| Apr 30, 2025 | 1.36 Mn |
| Jan 31, 2025 | 1.00 |
| Oct 31, 2024 | 9,013.00 |
| Jul 31, 2024 | -58,484.00 |
| Apr 30, 2024 | 144,014.00 |
| Jan 31, 2024 | -247,723.00 |
| Oct 31, 2023 | 271,896.00 |
| Jul 31, 2023 | 21,736.00 |
| Apr 30, 2023 | 76,401.00 |
| Jan 31, 2023 | -67,956.00 |
| Oct 31, 2022 | -80,476.00 |
| Jul 31, 2022 | 31,322.00 |
| Apr 30, 2022 | 29,699.00 |
| Jan 31, 2022 | 491,033.00 |
| Oct 31, 2021 | -501,117.00 |
API Access
PharmaCyte Biotech Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();